Immuron Valuation
IMRN Stock | USD 2.15 0.17 8.59% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Immuron Ltd ADR retains a regular Real Value of $2.66 per share. The prevalent price of the firm is $2.15. Our model calculates the value of Immuron Ltd ADR from evaluating the firm fundamentals such as Return On Asset of -0.17, current valuation of 5.89 M, and Return On Equity of -0.43 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Immuron's price fluctuation is very risky at this time. Calculation of the real value of Immuron Ltd ADR is based on 3 months time horizon. Increasing Immuron's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Immuron is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Immuron Stock. However, Immuron's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 2.15 | Real 2.66 | Hype 2.19 | Naive 2.33 |
The intrinsic value of Immuron's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Immuron's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Immuron Ltd ADR helps investors to forecast how Immuron stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Immuron more accurately as focusing exclusively on Immuron's fundamentals will not take into account other important factors: Immuron Total Value Analysis
Immuron Ltd ADR is currently projected to have valuation of 5.89 M with market capitalization of 13.03 M, debt of 173.5 K, and cash on hands of 22.11 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Immuron fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
5.89 M | 13.03 M | 173.5 K | 22.11 M |
Immuron Investor Information
The company has price-to-book (P/B) ratio of 1.55. Some equities with similar Price to Book (P/B) outperform the market in the long run. Immuron Ltd ADR recorded a loss per share of 0.76. The entity had not issued any dividends in recent years. Based on the analysis of Immuron's profitability, liquidity, and operating efficiency, Immuron Ltd ADR is not in a good financial situation at this time. It has a very high odds of going through financial crisis in February.Immuron Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Immuron has an asset utilization ratio of 31.53 percent. This suggests that the Company is making $0.32 for each dollar of assets. An increasing asset utilization means that Immuron Ltd ADR is more efficient with each dollar of assets it utilizes for everyday operations.Immuron Ownership Allocation
The market capitalization of Immuron is $13.03 Million. Roughly 99.82 (percent) of Immuron outstanding shares are held by general public with 0.18 pct. by outside corporations. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Immuron Profitability Analysis
The company reported the previous year's revenue of 4.9 M. Net Loss for the year was (6.94 M) with profit before overhead, payroll, taxes, and interest of 3.34 M.About Immuron Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Immuron Ltd ADR. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Immuron Ltd ADR based exclusively on its fundamental and basic technical indicators. By analyzing Immuron's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Immuron's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immuron. We calculate exposure to Immuron's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Immuron's related companies.Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia. Immuron operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.
Immuron Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 228.2 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuron Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immuron. If investors know Immuron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immuron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immuron Ltd ADR is measured differently than its book value, which is the value of Immuron that is recorded on the company's balance sheet. Investors also form their own opinion of Immuron's value that differs from its market value or its book value, called intrinsic value, which is Immuron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immuron's market value can be influenced by many factors that don't directly affect Immuron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immuron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immuron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.